Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude
This study examines the bacteria that live in children's intestines and how they affect growth and immune function at high altitudes. Researchers will compare intestinal bacteria composition in children living in different altitude regions to understand how location and diet influence these bacterial communities.
Key Objective: The trial aims to identify how intestinal bacteria at high altitudes affect children's growth and immune system development.
Who to Consider: Healthy children living at various altitudes who are interested in contributing to research on how environment affects intestinal health and immune function.
Trial Parameters
Brief Summary
Microbes and the human body maintain a complex relationship of interaction and influence. Different regions, altitudes, and dietary habits have different degrees of influence on the composition of children's intestinal flora. Therefore, the development and maturation process of children's intestinal flora in plateau areas was discovered, and its relationship with children's immunity, metabolism, and growth was understood. The mechanism of action of children's intestinal flora on immunity, growth and development was further analyzed by comparing it with people in low-altitude areas, to provide a scientific basis for improving children's health in plateau areas.
Eligibility Criteria
Inclusion Criteria: * Children aged 1-3 years old * Both men and women; * The child's legal guardian signed the informed consent to participate in the study. * The legal guardian of the child commits to follow the study procedures and cooperate with the entire study process Exclusion Criteria: * Probiotics or antibiotics within 1 month * Associated with clinically significant abnormalities in liver and kidney function, nervous system, respiratory system, and coagulation function as determined by the investigator * Unstable vital signs; * Have other underlying medical conditions * Individuals deemed unsuitable for this clinical trial.